Relationship between cytochrome P450 2C19*2 polymorphism and stent thrombosis following percutaneous coronary intervention in Chinese patients receiving clopidogrel.

Item

http://www.wikidata.org/entity/Q54337089

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Relationship between cytochrom ...... atients receiving clopidogrel.

@en

Relationship between cytochrom ...... atients receiving clopidogrel.

@nl

type

Item

label

Relationship between cytochrom ...... atients receiving clopidogrel.

@en

Relationship between cytochrom ...... atients receiving clopidogrel.

@nl

prefLabel

Relationship between cytochrom ...... atients receiving clopidogrel.

@en

Relationship between cytochrom ...... atients receiving clopidogrel.

@nl

P1476

Relationship between cytochrom ...... atients receiving clopidogrel.

@en

P2093

A Verdo

http://www.w3.org/2001/XMLSchema#string

B Hu

http://www.w3.org/2001/XMLSchema#string

D-F Zhang

http://www.w3.org/2001/XMLSchema#string

W-G Qi

http://www.w3.org/2001/XMLSchema#string

Y Luo

http://www.w3.org/2001/XMLSchema#string

Y-T Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

Clopidogrel resistance?

Clinical relevance of genetic polymorphisms in the human CYP2C subfamily

Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents.

Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.

First analysis of the relation between CYP2C19 genotype and pharmacodynamics in patients treated with ticagrelor versus clopidogrel: the ONSET/OFFSET and RESPOND genotype studies.

Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction.

Clinical end points in coronary stent trials: a case for standardized definitions.

Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis.

Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10 + 12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients.

P304

2012-2019

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/147323001103900548

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51835018

http://www.w3.org/2001/XMLSchema#string

P698

22118006

http://www.w3.org/2001/XMLSchema#string

P921

thrombosis

clopidogrel